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Abstract
The essential herpesvirus adaptor protein HVS ORF57, which has homologs in all other herpesviruses, promotes viral mRNA
export by utilizing the cellular mRNA export machinery. ORF57 protein specifically recognizes viral mRNA transcripts, and
binds to proteins of the cellular transcription-export (TREX) complex, in particular ALYREF. This interaction introduces viral
mRNA to the NXF1 pathway, subsequently directing it to the nuclear pore for export to the cytoplasm. Here we have used a
range of techniques to reveal the sites for direct contact between RNA and ORF57 in the absence and presence of ALYREF. A
binding site within ORF57 was characterized which recognizes specific viral mRNA motifs. When ALYREF is present, part of
this ORF57 RNA binding site, composed of an a-helix, binds preferentially to ALYREF. This competitively displaces viral RNA
from the a-helix, but contact with RNA is still maintained by a flanking region. At the same time, the flexible N-terminal
domain of ALYREF comes into contact with the viral RNA, which becomes engaged in an extensive network of synergistic
interactions with both ALYREF and ORF57. Transfer of RNA to ALYREF in the ternary complex, and involvement of individual
ORF57 residues in RNA recognition, were confirmed by UV cross-linking and mutagenesis. The atomic-resolution structure
of the ORF57-ALYREF interface was determined, which noticeably differed from the homologous ICP27-ALYREF structure.
Together, the data provides the first site-specific description of how viral mRNA is locked by a herpes viral adaptor protein in
complex with cellular ALYREF, giving herpesvirus access to the cellular mRNA export machinery. The NMR strategy used
may be more generally applicable to the study of fuzzy protein-protein-RNA complexes which involve flexible polypeptide
regions.
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Introduction
Mammalian gene expression is coupled with mRNA matura-
tion, where nascent transcripts undergo a continuous series of
splicing and processing events finally leading to nuclear export to
the cytoplasm [1]. This process is tightly regulated and orches-
trated, ensuring that only mature and fully-processed cellular
mRNA is exported from the nucleus, to be correctly translated into
proteins in the cytoplasm. The recruitment of protein markers
acquired during this maturation process, such as UAP56, UIF and
ALYREF (otherwise known as Aly, REF, Aly/REF, REF/Aly,
BEF, Thoc4 in metazoan and Yra1 in yeast), is essential for the
export of cellular mRNA via the NXF1 pathway (otherwise known
as TAP) [2–4]. These markers are part of the multicomponent
TREX complex which associates with the 59 end of cellular
mRNAs during splicing [3]. TREX recruits NXF1 to mRNA and
TREX triggers a conformational change in NXF1, such that it
binds mRNA with high affinity [5,6]. The cellular protein
ALYREF functions as an export adaptor, binding mRNA as part
of TREX, and also interacting with NXF1 [7,8]. The structure of
ALYREF has been characterized: it consists of central folded
RRM domain [9] flanked by two largely flexible multifunctional
N- and C-terminal domains [10]. ALYREF primarily uses its N-
terminal flexible arginine-rich region for interaction with NXF1;
this region closely overlaps with the RNA binding site [10]. The
arginines within this region become methylated, which reduces its
RNA binding activity and may serve as a control mechanism for
RNA displacement from ALYREF to NXF1 [11]. ALYREF and
Thoc5 binding remodels NXF1, increasing its binding affinity for
mRNA, ensuring transfer of mRNA to NXF1 [5,6]. NXF1 then
introduces the mRNA to nucleoporins, committing it to exit from
the nucleus through the nuclear pore [12–14].
Herpesviridae possess an intriguing ability to circumvent the
sophisticated cellular controls which ensure that only mature
spliced mRNA can be exported from the nucleus. Viral mRNA is
generally unspliced, therefore it cannot acquire the normal protein
markers during splicing, which would signal that mRNA is ready
for export to the cytoplasm. However, all herpesviruses express an
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essential multi-functional adaptor protein which specifically
recognizes viral mRNA, and bridges its interaction with TREX
complex via binding to cellular mRNA export factors such as
ALYREF and UIF [15–19], for subsequent export via the NXF1
pathway [20–23]. It was also recently suggested that ALYREF
may be recruited by viral adaptors to stabilize the viral nuclear
RNAs independently of their export [24]. The infected cell protein
27 (ICP27) from Herpes Simplex Virus type 1 (HSV-1) is probably
one of the most well-studied examples of the viral multifunctional
adaptors [25]. In Herpesvirus Saimiri (HVS), which is the
prototype c-2 herpesvirus with close similarity to human Kaposi’s
Sarcoma-associated herpesvirus (KSHV), a similar function is
carried out by the protein ORF57 [21,23]. Homologs of these
adaptor proteins are also known as ORF57 in KSHV [26,27],
EB2 in Epstein-Barr virus (EBV) [28], and UL69 in the human
cytomegalovirus [29]. All these viral adaptor proteins contain long
intrinsically-unstructured but functionally-important regions, with
relatively poor sequence homology. Although these proteins
appear to have a very similar function in promoting viral mRNA
export via the cellular NXF1 pathway, the location and
appearance of their RNA-binding regions vary, and the precise
location of ALYREF binding sites cannot be inferred from their
amino acid sequences. How exactly they perform their viral
mRNA export function, and introduce viral mRNA to cellular
proteins such as ALYREF, has not been described in detail yet.
Recently, the structure of the interaction interface between
HSV-1 adaptor protein ICP27 and cellular mRNA export factor
ALYREF was determined [30]. (It should be noted that while in
our previous study [30] ALYREF protein was referred to as REF,
due to recent recommended changes by the HUGO Gene
Nomenclature Committee [31] here we will be referring to the
same protein as ALYREF). In this structure, interaction with the
RRM domain of ALYREF is achieved via a very short peptide
fragment of the flexible N-terminal region of ICP27 [30].
Additionally, a ALYREF-interacting region aa103–120 was
mapped on HVS ORF57 protein [30]. The mostly unstructured
ORF57 region aa8–120 [30] mediates specific recognition of HVS
mRNA via the viral RNA sequence motif GAAGRG [32].
Although this ORF57 fragment contains an arginine-rich region, it
lacks any canonical RNA-binding sequence features such as an
RGG box, which is present in ICP27 [33,34]. Therefore, the exact
location of the RNA binding site remained unknown, along with
the mechanism of RNA transfer from ORF57 to ALYREF. Which
protein sites are involved at different stages of such a transfer?
What is the structure of the ternary ORF57-RNA-ALYREF
complex? Answers to these questions would enable further
functional and mutagenesis studies, to reveal how the assembly
and disassembly of complexes involved in RNA recognition,
transfer and export are achieved at the molecular level [35,36].
In this study we used solution state NMR to reveal molecular
details of the ternary complex assembly of functional fragments of
HVS ORF57, HVS RNA and ALYREF, and suggest a model for
the mechanism of RNA transfer between protein molecules in this
system. The mapping experiments show a clear difference between
binding of non-specific random-sequence RNA oligos, and RNA
oligos containing HVS-specific sequence motifs, to a flexible
arginine-rich region of ORF57. We reveal that for the ORF57
protein, its ALYREF binding site also forms part of the specific
viral RNA recognition region, with adjacent arginine-rich
sequences also contributing to RNA binding. We present the
atomic-resolution structure of the ORF57-ALYREF binding
interface, which somewhat differs from that of ICP27-ALYREF
identified earlier [30]. Using a new strategy based on principles of
saturation-transfer (ST) between molecules [37] and isotopically-
discriminated NMR [38], we followed the changes in RNA
binding sites which accompany transfer of RNA from one protein
molecule to another. In the ternary ORF57-RNA-ALYREF
complex, RNA is partially displaced from its binding site on
ORF57 by ALYREF, but is retained in the complex by the
synergistic action of flanking flexible regions of both ALYREF and
ORF57. The detailed model obtained based on NMR data was
supported by mutagenesis studies, and cooperativity in ternary
complex assembly was additionally characterized by fluorescence
measurements.
Results
Mapping the specific HVS mRNA binding site on ORF57
Previously the recognition of specific short viral mRNA
sequences was attributed to Herpesvirus saimiri ORF57 protein
region aa8–120 [32], however the precise binding site within this
fairly long region was unknown, and no obvious sequence patterns
(such as RGG boxes) indicative of RNA-binding sites could be
identified. To locate the RNA-binding regions experimentally
within ORF578–120, and study specific vs non-specific binding, we
used NMR spectroscopy. Sequence specific signal assignments of
all amides of ORF578–120 allowed the mapping of interaction sites
to a residue-level resolution. The unlabelled RNA oligonucleotides
were added to 15N-labelled protein samples and residue-specific
signal changes were monitored. The effect of non-specific RNAs of
different lengths (oligonucleotides named 7merN and 15merN, see
Materials section) on signal position and shape were compared
with ORF57-specific RNA oligos (7merS and 14merS) containing
the previously identified HVS motif GAAGAG [32] (Fig. 1A and
Fig. S1A). For non-specific 7merN and 15merN (even at two-fold
excess) the amide signal changes in ORF578–120 were small and
scattered across the entire sequence (Fig. S1A), suggesting only
transient non-specific binding. Similarly, addition of a two-fold
excess of non-specific 7merN caused no significant change in local
mobility of the ORF57 polypeptide chain, as evidenced by
15N{1H}-NOE both for the ORF578–120 and ORF5756–140
constructs (Fig. S1B). (The latter construct was used as a control
to ensure that the absence of binding with 7merN is not an artifact
of C-terminal truncation of a potential binding site). In contrast,
Author Summary
Herpes viruses invade cells, hijacking cellular components
to sustain their lifecycle and replicate. A critical step of
infection is the export of viral mRNA from the nucleus to
the cytoplasm, where the molecular machinery to produce
proteins is located. To provide a link between their mRNA
and cellular components of the mRNA export pathway, all
herpesviruses use special adaptor proteins. These adaptor
proteins specifically select viral mRNAs from the mixture
present in the nucleus, and introduce them to cellular
mRNA export factors, such as ALYREF. How these viral
adaptors manage to trick ALYREF to accept foreign genetic
material has not been understood on a molecular level. In
this study we reveal how a typical viral adaptor protein
ORF57 recognizes specific viral RNA motifs, and also how it
binds to the cellular protein ALYREF. We uncover details of
how ORF57 transfers the viral RNA to ALYREF, locking it in
the cooperative ternary complex. We also describe the
atomic-resolution structure of ORF57-ALYREF interaction
interface. Together the data provides the first molecular
insight of how viral mRNA is transferred between viral and
cellular proteins, thus helping virus to hijack a cell.
Viral mRNA Transfer from HVS ORF57 to ALYREF
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the ORF57-specific oligos caused substantial signal broadening in
all signals corresponding to the region aa64–120 (Fig. 1A). The
severity of signal perturbations was also dramatically dependent on
the length of the oligo used, reflecting differences in the apparent
affinity of RNA binding. For specific 7merS, all signals within the
aa64–120 region were broadened beyond detection once a 1:1
stoichiometry was reached, whereas for 14merS, equivalent signal
loss occurred at 0.2:1 RNA:protein ratio. Notably, the ALYREF-
binding region aa103–120 [30] was affected most severely by the
addition of RNA, suggesting that the RNA and ALYREF-binding
sites partially overlap. To determine if this ALYREF binding
region is sufficient for specific RNA binding, the short ORF57103–
120 peptide was titrated with 7merS, however no NMR signal
broadening occurred and only small signal perturbations (under
0.04 ppm) were observed even with a 3-fold excess of RNA (Fig.
S1C). Signal perturbation mapping therefore suggested a specific
RNA binding site encompassing aa64–120 within ORF578–120,
whilst also showing the ALYREF-binding region aa103–120
located within this site is not sufficient for the recognition of
specific viral RNA. Fluorescence measurements were also used to
estimate the Kd for 14merS binding as 7.5760.06 mM, compared
to 38.860.6 mM for 7merN (Fig. S7A,B).
Unexpectedly, the addition of both specific and non-specific
RNA oligos caused small NMR signal shifts in the acidic region of
ORF578–120 (aa10–40). We could not observe intermolecular
NOEs between RNA and protein for the definitive binding epitope
mapping, therefore, to separate possible indirect effects of
conformational changes on signal shifts brought about by RNA
binding and identify direct points of contact, we used RNAR
ORF57 cross saturation transfer (ST) experiments [37,39] (see Fig.
S1D). These experiments report directly on the spatial proximity
of RNA moieties to NH groups of individual amino acid residues
(contact distance ,5 A˚), and provide essentially the same type of
information as traditional RNA-protein cross-linking assays,
but in a site-specific manner. A sample containing 15N-labelled
ORF578–120 : RNA 7merS in a ratio of 1:0.5 was prepared (higher
RNA concentrations prevented measurements due to excessive
signal broadening). Selective saturation of RNA signals with a
series of radiofrequency pulses resulted in a significant decrease in
signal intensity of the backbone amides in 1H-15N correlation
spectra (relative to the reference spectrum with off-resonance
saturation) of mainly aa107–120 and aa81–92, and to a lesser
extent, aa94–105, and even less, aa64–79 (Fig. 1A and Fig. S1E).
(The typical effects of RNARORF57 saturation transfer on
selected example signals from amides non-adjacent and adjacent
to RNA are shown on the bottom right traces of the Figure
‘‘Typical effects of complex formation and RNARprotein ST’’
introduced later in the Results section.) The RNARORF57 ST
experiment was repeated as a control with non-specific RNA
7merN, but no site-specific saturation transfer, and hence no direct
interaction, was detected even when using a 2-fold excess of RNA
(Fig. 1A and Fig. S1E). Based on the results of saturation transfer
mapping, which are also in line with signal perturbation mapping,
we conclude that ORF578–120 contacts the specific RNA motifs
directly using primarily its regions aa107–120 and aa81–92, with
additional contribution from residues within aa94–105 and aa64–
79. No significant binding was detected with non-specific RNA of
similar length.
Previously we mapped aa103–120 as the ALYREF interaction
site in HVS ORF57 [30]. Here, residues within the same region
Figure 1. Overview of RNA interaction sites mapped on ORF578–120 and ALYREF1–155 using different approaches. Backbone amide
chemical shift change (dCS) and saturation transfer (ST) data are shown for ORF578–120 (A) and ALYREF1–155 (B) with different ligands added as
labeled. Crosses indicate residues with signal broadened beyond detection. For dCS, large (.0.1) and moderate (.0.04) chemical shift changes of
each protein relative to signals in its free state, are shown as solid and broken bars, respectively. For ST data, signal intensity ratios significantly
different from the background mean values are represented by solid (.6 SD) and broken (.3 SD) bars, respectively. Labels indicate the state of the
protein for each dataset, data shown for interactions with non-specific RNA (green), ORF57 specific RNA (red/orange) and ALYREF-ORF57-RNA
complex (blue).
doi:10.1371/journal.ppat.1003907.g001
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were also implicated in binding with a specific RNA motif. Given
the multi-functional importance of this region, we endeavored to
characterize it structurally. The secondary structure prediction
algorithms Psipred [40] and Agadir [41] suggest ORF57
aa108–118 should be a-helical. Our experimental NMR data,
namely dihedral angles derived from TALOS+ [42], 15N[1H] NOE
experiments, and presence of characteristic i to i+3 NOEs for a
shorter peptide ORF57103–120 (see Fig. S2), also all demonstrate that
the ORF578–120 site aa107–118 exists in a-helical conformation;
therefore this region was named ‘‘R-b helix’’.
Solution structure of the ALYREF-ORF57 interaction
interface
Previously the structure of the complex of ALYREF fragment
aa54–155 (ALYREF54–155) with ORF578–120 could not be
determined due to an unfavorable chemical exchange regime,
causing signal broadening for the interacting residues [30]. In view
of the importance of the aa103–120 region for both ALYREF and
RNA binding, and differences in local structure of ALYREF-
binding regions of ICP27 [30] and ORF57, we pursued the
structure of the ORF57-ALYREF complex interface. We
employed a short ORF57103–120 construct, which displayed much
improved spectra and less exchange behavior (Fig. S3). The
atomic resolution structure of the ALYREF54–155 - ORF57103–120
complex was determined using a total of 2427 non-redundant
NOEs, 122 of which were intermolecular (Table 1 and Fig. S4).
Previous signal perturbation mapping indicated that ORF57
aa103–120 comprise the ALYREF-binding site [30]; the new data
defined the site more precisely as aa106–120 (Fig. S3C). Within
the complex, the ORF57 peptide is a-helical for aa108–119,
contacting the loops L1 and L5 on the a-helical face of ALYREF
(Fig. 2). The binding site on ALYREF is composed of a
hydrophobic patch formed by the sidechains of L82, V86, L94,
Y135, V138, L140 and M145, with E93 and E97 contributing to
ionic interactions (Fig. 2D). The aromatic sidechain of W108ORF57
is positioned at one end of this hydrophobic patch of ALYREF in
close proximity to the sidechain of V86 (Fig. 2D). The majority of
the remaining hydrophobic contacts of ORF57 are formed by
V112 and the aliphatic part of the R113 sidechain, with A109,
A115 and A116 also contributing. The positive charged
R113ORF57 sidechain is positioned between ALYREF residues
E93 and E97 which are therefore likely to form salt bridges. The
structure reveals unexpected differences in binding conformations
and molecular recognition of two functionally-similar viral adaptor
proteins, HVS ORF57 and HSV-1 ICP27, on essentially the same
site on ALYREF (Fig. 3 and Fig. S3D), despite the presence of
deceptively similar recognition triads identified earlier [30].
Viral RNA binds to ALYREF only weakly, as detected by
NMR
ALYREF is known to bind RNA weakly and non-specifically,
primarily using its flexible N- and C-terminal domains [7]. Using
NMR signal perturbations, non-specific 15-mer RNA (15merN)
oligonucleotide binding to the ALYREF fragment aa1–155
(ALYREF1–155) was previously mapped to RGG motifs situated
within its unstructured N-terminus and also to loops L1 and L5 of
the RRM domain [10]. To address how well ALYREF binds to
the viral mRNA specifically recognized by ORF57, we firstly
explored how ALYREF binding to RNA depends on the length of
the viral oligo sequence. Chemical shift mapping was carried out
with [15N]-REF1–155 using equimolar 7merS or 14merS (Fig. 1B).
The data indicated that the short RNA 7merS causes small
perturbations almost exclusively within the RRM domain in loops
L1, L3 and L5, whereas the longer 14merS caused signal
broadening within the N-terminal aa12–48 along with minor shift
changes within the RRM. The extent and location of signal
changes is similar to that observed previously using non-specific
15-mer RNA (15merN) [10], suggesting that ALYREF itself
cannot discriminate between viral and non-viral RNA, and binds
it only weakly. Saturation transfer experiments confirmed that
14merS RNA contacts ALYREF in the N-terminal region
containing RGG motifs (Fig. 1B and Fig. S1F), at the same site
where non-specific RNA binding occurs. The measurement of the
Kd for ALYREF
1–155 interaction with RNA oligonucleotides using
fluorescence unfortunately could not be completed due to increase
in sample turbidity upon RNA addition, likely caused by non-
specific protein aggregation. From NMR titration data the lower-
limit Kd estimates for 7merS and 14merS binding were .100 mM
and .50 mM, respectively. These values are significantly higher
than the values characterizing the specific binding of the 14merS
to viral ORF578–120 (7.57 mM, Fig. S7A), and closer to the Kd for
non-specific binding of 7merN to ORF578–120 (38.8 mM, Fig.
S7B). Overall, these estimates show that the viral RNA motif is
specifically recognized and binds with viral ORF578–120 but not
ALYREF1–155, suggesting that in the cell the viral mRNA would
be initially preferentially recognized and bound by viral ORF57.
Table 1. NMR calculation statistics for an ensemble of the 20
lowest energy structures of ALYREF fragment (ALYREF54–155)
bound to ORF57103–120 (PDB code 2YKA).
Total number of NMR restraints 2629
Number of NOE restraints 2427
Intra-residue 534
Sequential 651
Medium range (2#i#4) 448
Long range intramolecular (5#i) 794
Intermolecular 122
Dihedral 164
Hydrogen bonds 38
Mean number of NOE violations .0.1 A˚ 0.010860.0010
Mean number of dihedral violations .5u 0.314460.0375
Mean Cyana target function, A˚2 1.5860.18
Coordinate precision, A˚
RMSD (ALYREF74–152+ORF57106–120)
Backbone 0.2660.07
Heavy atom 0.8160.08
RMSD (ALYREF74–152)
Backbone 0.2160.05
Heavy atom 0.7360.06
RMSD (ORF57106–120)
Backbone 0.2960.13
Heavy atom 1.0160.19
Ramachandran plot (ALYREF74–152+ORF57106–120),
% residues in regions:
Favored 79.8
Additional 20.2
Generous 0.0
Disallowed 0.0
doi:10.1371/journal.ppat.1003907.t001
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Competition between ALYREF and RNA for binding to
R-b helix of ORF57 monitored by IDIS NMR experiments
As shown above, the ORF57 region aa106–120 is involved in
specific viral RNA binding, but it can also be utilized for ALYREF
binding. This raises the question: which binding partner does this
particular region select when all three components are present?
Here we used solution NMR experiments to investigate directly if
these local interactions are indeed competitive, and which of these
is stronger and hence is preferentially selected when the ternary
complex is formed. Residue-specific signal changes in the ORF57-
ALYREF complex upon addition of unlabelled RNA were
monitored using an IDIS-TROSY experiment [38], which allows
the observation of separate 1H-15N-correlation spectra of two
differentially-labeled proteins in the same sample. At a stoichio-
metric 1:1 ratio of [15N,13C]- ORF578–120 and [15N]-REF1–155,
the backbone amides at the protein-protein interface are exchange
broadened (including aa106–120 of ORF57), however signals
from other regions of both proteins are clearly observable, and
their pattern is characteristic of ORF57-ALYREF complex
formation. Having been assigned to particular amino acid
residues, they were able to report site-specific changes in the
protein-protein interactions in response to ligand binding (Fig. 1,
Fig. S5 and Fig. S6).
In an initial experiment, a stoichiometric equivalent of a shorter
specific RNA 7merS was added to the differentially-labeled
ORF57-ALYREF complex. In contrast to the substantial broad-
ening of aa64–120 observed on addition of 7merS to free
ORF578–120, no broadening and only small shifts in ORF57
signals were observed when ALYREF was present (Fig. 1). This
indicates that ALYREF reduces ORF57 binding to specific viral
RNA, protecting its binding site, aa106–120. A control experiment
using ALYREF54–155, which lacks the N-terminal RNA binding
site, produced similar results, also suggesting that the region
aa106–120 of ORF57 has higher affinity for ALYREF than for a
specific RNA oligo 7merS (Fig. S6). The ALYREF signal changes
induced by the addition of 7merS were marginal. In a related
experiment, to directly follow the displacement of RNA from
ORF57, one equivalent of the 7merS was added to [15N]-
ORF578–120 causing substantial signal broadening in aa64–120.
Then one equivalent of [15N,13C]-REF1–155 was added to the
same sample, resulting in recovery of all ORF57 signals except for
those which became instead involved in the ALYREF interaction
(aa106–120) and remained broad. IDIS-TROSY spectra of both
ALYREF and ORF57 confirmed formation of the protein-protein
complex as the fingerprint pattern of observable ORF57 signals
was consistent with ORF57 bound to ALYREF, but not RNA.
These direct experiments demonstrate that virus-specific RNA is
displaced from ORF57 aa106–120 by the competitive binding of
ALYREF to this region, and not by the preferential binding of
RNA to ALYREF.
RNA binding within the ternary RNA-ALYREF-ORF57
complex mapped by ST IDIS NMR experiments
As the short RNA 7merS cannot be bound efficiently by the
ORF57-ALYREF complex, subsequent experiments were per-
formed using a longer specific RNA 14merS. Importantly, as
evidenced by the presence of a large number of relatively sharp
signals from amide groups of both proteins (Fig. 4, Fig. 5, Fig. S5,
Fig. S6), the complexes formed retained a high degree of flexibility,
even for residues directly involved in interactions. There were no
NOE signals observed between RNA and proteins, making it
impossible to apply standard techniques for full 3D structure
determination of the ternary complex. Therefore, to obtain
information regarding the spatial organization of this largely fluid
assembly, a saturation-transfer version of isotopically-discriminat-
ed TROSY [38] experiment (ST-IDIS-TROSY) was created and
used to detect directly, in residue-specific manner, where exactly
RNA contacts the ALYREF1–155 and ORF578–120 in the ternary
complex (Fig. 4). A sample was prepared containing a 1:1:1
mixture of [15N,13C,2H]-ORF578–120, [15N,2H]-REF1–155 and
non-labeled 14merS (,40 kDa complex in total). Protein deuter-
ation was used to improve the quality of spectra and reduce
possible artifacts due to spin diffusion effects [37]. RNA proton
signals were selectively saturated by radiofrequency pulses [37,39],
and changes in IDIS-TROSY [38] peak intensities were moni-
tored to reveal which amide groups are situated in close proximity
(,5 A˚) to RNA moieties, observing fingerprint spectra from both
proteins at once (Fig. 4B). The examples of typical changes in
individual signals (from interacting and non-interacting sites) in
response to complex formation and saturation transfer are shown
for illustration on Fig. 5, with residue-specific results presented in
Fig. S1G,H, and an overview is included in Fig. 1. When the
saturation transfer effect was initially calculated from the ratio
I5.85/I21.0 obtained with on-resonance ribose proton (5.85 ppm)
and off-resonance (21.0 ppm) saturation, we noticed a significant
amount of non-specific saturation transfer to virtually all serine
residues in ORF57. We explained that by the inadvertent
saturation of serine hydroxyl groups. To compensate for this
effect, we have used two different saturation schemes. In the first
scheme, we selectively saturated two RNA resonances (moieties)
with similar chemical shifts (5.75 and 5.85 ppm), and calculated
the ratio of signal intensities I5.75/I5.85 (Fig. S1G). If one of the
saturated RNA moieties is positioned closer to a protein amide
Figure 2. Structure of the ALYREF – ORF57 complex. (A) Ribbon
representation showing ORF57 colored blue, and ALYREF RRM colored
green, red and yellow for looped, a-helical and b-sheet regions,
respectively. Positions of N- and C-termini of polypeptide chains are
labeled. (B) Overlay of 20 lowest energy structures with backbone
shown in the same orientation. The best-fit superposition is made using
heavy backbone atoms of structurally defined regions aa74–152 of
ALYREF and aa108–119 of ORF57. Color-coding is the same as on panel
A. (C) Alternative view of ALYREF54–155-ORF57103–120 complex showing
the hydrophobic sidechains involved in the interaction. (D) Schematic
of the ALYREF and ORF57 binding site. ORF57 residues are colored blue
and ALYREF in black; hydrophobic and electrostatic interactions are
indicated by green and red dashes, respectively.
doi:10.1371/journal.ppat.1003907.g002
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group (and within 5 A˚) than the other, then the amount of cross-
saturation transfer from them to this amide will not be equal.
Hence, where the ratio I5.75/I5.85 deviates from unity, it
highlights residues adjacent to RNA. The close positioning of
saturating frequencies on the other hand should cross-saturate
broad hydroxyl signals to a similar extent, compensating for this
artifact. In the second scheme, the on-resonance saturation was
centered at 12.0 ppm and off-resonance at 21.0 ppm, and I12.0/
I21.0 ratio calculated (Fig. S1H). The RNA signals at 12.0 ppm
were broad and not observable, but this frequency was chosen as
it is characteristic for RNA imino protons. Both saturation
schemes led to similar mapping results: whereas many protein
amide resonances remained unaffected by the RNA signal
saturation, several regions in ALYREF and ORF57 in the
ternary complex were clearly highlighted (Fig. 1 and Fig. S1G,H).
The most pronounced ST effect was observed for the arginine-
rich N-terminal region of ALYREF aa24–48, with parts of the
RRM domain also affected (Fig. 1B). The region aa79–100
within ORF57 was also highlighted by saturation transfer, as seen
by the deviations of the I5.75/I5.85 and I12.0/I21.0 ratios from
unity. The increase in estimated error margins within the regions
affected by ST (Fig. S1G,H) is explained by signal broadening,
leading to a reduction of signal intensities for amides in contact
with RNA. The presence of ALYREF in the sample clearly
reduces the size of the ORF57 site available for RNA binding
(Fig. 1A). In the presence of ORF57, the saturation transfer from
RNA 14merS to ALYREF becomes more pronounced (i.e., larger
deviation of Ifreq1/Ifreq2 from unity), suggesting that RNA is
retained by ALYREF within the ternary complex more efficiently
than by ALYREF alone.
The NMR experiments therefore all indicate that ALYREF
partially displaces the viral RNA initially bound specifically to
ORF57, but retains it within the complex. In the ternary complex
ORF57 aa106–120 directly interacts with the ALYREF RRM,
whereas flexible flanking regions of ALYREF (aa24–48) and
ORF57 (aa81–92), and to lesser extent, parts of helix 2 of the
ALYREF RRM, jointly keep hold of the viral RNA molecule.
Interestingly, amide signals from flexible protein regions which
become involved in direct contacts with RNA (as evidenced by
RNA-protein saturation transfer), are only partially broadened in
the complex. They had intensities higher than signals from the
folded regions, but lower than signals from the unfolded non-
interacting regions (examples of this behavior can be seen in Fig. 5
and Fig. S5). This suggests that the interaction with RNA in these
conditions was somewhat transient and did not lead to the
formation of a rigid 3D structure.
Figure 3. Comparison of ALYREF54–155-ORF57103–120 with ALYREF54–155-ICP27103–138 and U2AF complex structures. (A) Overlay of the
RRM domains of ALYREF in complex with ICP27103–138 (green and magenta, PDB code 2kt5 [30]) and ORF57-bound ALYREF determined here (cyan
and orange), demonstrating the shift in a-helix 1 position. (B) ALYREF54–155 in complex with ORF57103–120, determined here. (C) Backbone amide
weighted chemical shift changes (dCS) in the ALYREF54–155-ORF57103–120 complex are emphasized by color. dCS.0.3 are red, 0.15–0.299 orange, 0.05–
0.149 yellow, prolines are blue and regions unaffected are green. (D) U2AF35 in complex with U2AF65 (PDB code 1jmt, [50]). (E) ALYREF54–155 in
complex with ICP27103–138, previously determined (pdb 2kt5). (F) Backbone amide weighted chemical shift changes (dCS) in the ALYREF54–155-
ICP27103–120 complex with the same coloring as panel C.
doi:10.1371/journal.ppat.1003907.g003
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Cooperativity of RNA - ALYREF - ORF57 complex
assembly studied by fluorescence
Fluorescence measurements were used to quantify the overall
strength of the ALYREF1–155 and ORF578–120 interaction in the
absence and presence of a specific fragment of viral RNA. Both
protein constructs possess tryptophan residues, one of these (W108
of ORF57) forms part of their binding interface, and is buried
upon protein complex formation. Control experiments showed
that ALYREF1–155 and ORF578–120 both have a fluorescence
intensity maximum at 355 nm which is not shifted by 14merS
RNA addition (however, ALYREF samples become turbid due to
non-specific aggregation, complicating measurements). The for-
mation of equimolar ALYREF1–155 - ORF578–120 complex leads
to a blue shift of the emission maxima of the sample (Fig. S7C), in
agreement with burial of the tryptophan sidechain in a hydro-
phobic environment. The blue shift, quantified by lbcm, becomes
more pronounced with increasing concentrations of equimolar
ALYREF1–155 - ORF578–120 in the sample, allowing an estimation
of the apparent Kd for this interaction as 2.5660.20 mM (Fig.
S7C). Addition of 14merS to pre-mixed 10 mM equimolar
ALYREF1–155 - ORF578–120 complex caused both a decrease in
fluorescence intensity (DIN , reflecting the change from binary
protein-RNA to ternary complex formation), and a blue signal
shift (DlNbcm, reflecting the change from binary protein-protein to
ternary complex formation). Non-linear fit of the two dependen-
cies together to the three-equation equilibrium model using
DynaFit software [43] (see Fig. 6A) allowed an estimation of the
apparent macroscopic Kd for the RNA binding to ORF57-
ALYREF as 1.5560.24 mM. The overview of Kd’s determined for
this simplest equilibrium model for ternary complex formation
[44] is presented on a thermodynamic cycle in the inset of Fig. 6B.
The estimated value of Kd
OR+A = 0.52 mM for binding of ALYREF
to ORF57-RNA complex can be inferred from the thermody-
namic equilibrium considerations [44]. As the measured Kd values
for the formation of binary complexes are significantly higher than
for the ternary complexes (e.g., Kd
O+R = 7.57 mM.
Kd
OA+R = 1.55 mM), the assembly shows clear-cut cooperative
behavior [44]. These results therefore reveal that the ternary
complex formation, leading to introducing RNA to ALYREF, is
thermodynamically driven by the overall cooperativity. Further
analysis of this simplest equilibrium model using COPASI
simulations illustrates a dramatic increase in the population of
ALYREF molecules bound to RNA when the ORF57 is present
(Fig. 6B). We have also run COPASI simulations for an extended
binding model, where a very weak non-specific binding of RNA to
ALYREF (with estimated Kd.50 mM, see above) is taken into
account (Fig. 6C), and two different Kd values for non-specific
binding are assumed for calculations as examples. The COPASI
simulations for each model demonstrate that the presence of
ORF57 in stoichiometric amounts significantly increases the
concentration of ALYREF in complex with RNA (i.e., [OAR]),
compared to the background level of non-specific ALYREF-RNA
complex (i.e., [AR], Fig. 6B,C). Even with the most conservative
estimates (assuming the lowest value of Kd = 50 mM for non-
specific ALYREF-RNA binding), for the concentrations used in
this example the amount of virus-specific RNA in complex with
ALYREF increases more than 3.6 times.
Interestingly, adding a large excess of RNA to the 2.5 mM
ALYREF-ORF57 mixture displayed a more complex behavior of
signal shift (Fig. S7D): the blue shift observed with only a small
excess of RNA was partially reversed, consistent with protein-
protein complex dissociating at higher RNA excess. Intuitively this
result is expected if RNA over-saturates the binding site on
ORF57, competitively displacing ALYREF from R-b helix. This
competitive behavior at very high [RNA] cannot be adequately
described by currently parameterized simple equilibrium models,
such as shown on Fig. 6B,C, which only account for cooperativity.
The experimental fluorescence equilibrium binding data thus
reveal the overall cooperativity in the ternary complex formation
when the components are present at or near stoichiometric
amounts, and support a role of ORF57 as an adaptor introducing
RNA to ALYREF. The fluorescence data are also consistent with
a local competitiveness of ORF57-ALYREF and ORF57-RNA
interactions: this competitiveness becomes apparent at macro-
scopic (i.e., molecular) level only if RNA is in significant excess.
Figure 4. Obtaining site-specific information on RNA binding to protein-protein complex. (A) Scheme illustrating the principle of the ST-
IDIS-TROSY method proposed here. RNA is added to a differentially labeled pair of interacting proteins, and selective saturation of RNA protons by RF
pulses is transferred through space to the adjacent amides within both proteins in the complex. (B) The example of the resultant ST-IDIS-TROSY
spectra: signals from amide groups situated within 5 A˚ of the RNA are selectively weakened (colored red), as detected independently and
simultaneously in the spectra of both proteins.
doi:10.1371/journal.ppat.1003907.g004
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These observations fit well with the NMR experiments which
show the ability of ALYREF to partially displace RNA from R-b
helix of ORF57, while forming ternary complex.
RNA binding of ALYREF and ORF57 studied by UV cross
linking
The results of NMR mapping of RNA binding regions of
ORF578–120 were confirmed by UV cross-linking using purified
protein and radio-labeled RNA oligonucleotide, performed as
previously described [10]. The ORF57 mutants Y81A+R82A,
R88A+F89A and W108A+R111A+V112A all significantly re-
duced the efficiency of cross-linking with RNA 14merS (Fig. 7A).
Substitution of residues W108,R111,V112, which are the most
important for ALYREF binding [30], also has the strongest
reductive effect on RNA binding, confirming independently that
the RNA- and ALYREF-binding sites overlap. The control
mutation D110A+E114A marginally increases the efficiency of
RNA cross-linking, this is likely to be due to reduction in
electrostatic repulsion between this protein mutant and RNA.
To independently confirm the NMR observations in regard to
RNA oligonucleotide binding with ORF578–120, ALYREF1–155
and their complex, we performed in vitro reconstitution assays
followed by UV cross-linking experiments. ORF578–120 showed a
strong RNA-binding activity for 7merS and 14merS in sharp
contrast to GST-ALYREF which bound weakly with both RNAs
(Fig. 7B,C). When ORF578–120 was incubated with RNA prior to
mixing with GST-ALYREF, followed by GST affinity purification
of the resulting complexes and UV cross-linking, there was a
drastic reduction of the RNA cross-linked to ORF578–120 and a
concomitant increase in the RNA cross-linked onto GST-
ALYREF. Therefore the RNA-binding activity of ORF578–120 is
severely reduced upon interaction with ALYREF, whereas the
amount of RNA in contact with ALYREF increases in the ternary
complex. This independent data obtained at a molecular (i.e,
macroscopic) level concurs fully with the NMR data obtained at a
residue-specific level of detail. Interestingly, the increase in
ALYREF-RNA cross-linking efficiency observed experimentally
in the presence of ORF57 fits well with the numerical estimates
using COPASI simulations shown on Fig. 6C.
A molecular model for how viral mRNA is transferred
from viral ORF57 to cellular ALYREF
The combination of structural and interaction data allows us to
suggest a model that explains how the adaptor protein ORF57
from HVS introduces viral mRNA to cellular mRNA export factor
ALYREF, functioning as a molecular ‘‘hijacker’’. As previously
noted, ALYREF itself binds mRNA weakly and non-specifically,
and cannot discriminate between cellular and viral transcripts,
needing other proteins to recruit mRNA and strengthen this
binding to a functionally significant level. This non-specific
binding can be observed and mapped here by weak saturation
transfer from RNA to protein (Fig. 1). In its free form the N-
terminal region aa8–120 of ORF57 is flexible and mainly
unstructured, apart from the short a-helix aa108–118 which we
named R-b helix. It is anticipated that the positively charged
region aa61–120 interacts transiently with the negatively charged
part of the ORF57 polypeptide chain aa12–28, keeping the
molecule in a loosely ‘‘closed’’ conformation. When the specific
viral mRNA motif binds, it is recognized by the extensive ORF57
region aa64–120 which comprises R-b helix (see Fig. 8). On its
own, R-b helix is unable to bind RNA, but its presence, as well as
the presence of the flanking region, are essential. It can be
envisaged that the RNA-binding region of ORF57 may form a
hairpin or other compact structure to offer an extensive network of
contacts recognizing and holding the viral RNA molecule
(Fig. 8).The fragment aa64–120, which is rich with arginines,
serines and aromatic residues, forms direct contacts with RNA, but
without forming a stable 3D structure, and this RNA binding is
expected to release the negatively-charged N-terminal part of
ORF57. ORF57 is not able to recognize and bind mRNA which
lacks specific viral motifs, ensuring that this viral adaptor selects
only viral transcripts for further export. Although the R-b helix of
ORF57 participates in recognition and binding of viral mRNA, it
has much higher affinity for ALYREF binding. Therefore in the
presence of ALYREF (see Fig. 8), the R-b helix is released from
RNA and binds the RRM domain of ALYREF instead. However
at that point the adjacent flexible regions of both ORF57 and
ALYREF, which are also involved in RNA binding, are brought
together, and the viral RNA molecule is not released but is held in
place by the synergetic action of these flanking regions (Fig. 8).
The overall cooperativity of ternary complex assembly is
Figure 5. Typical effects of complex formation and RNARpro-
tein ST on selected signals of ALYREF1–155 and ORF578–120. The
1H dimension slices through 1H-15N-correlation spectra are displayed for
three representative signals of each protein, on the left for ALYREF and
on the right for ORF57. The residue assignments in the free form are
labeled at the top, and same signals are shown below each other for
different complexes, as indicated. First type of signal (ALYREFM1 and
ORF57E24) is not significantly affected by any complex formation, or ST.
Second type (ALYREFA34 and ORF57Y81) is not affected much by protein
and marginally affected by RNA binding, but is altered or displays
significant ST effect in the ternary complex (percentage drop in signal
intensity is indicated in blue, and ST spectral traces shown in red). These
are residues likely contributing to cooperative ternary complex
formation, forming contacts with RNA. Third type of signals originates
from the structured regions of proteins (ALYREFA104 and ORF57R111).
ALYREFA104 signal is not significantly affected in protein-protein
complex, but shows significant increase in ST effect in the ternary
complex, suggesting that ORF57 recruits RNA to the proximity of this
residue. ORF57R111 signal is broadened beyond detection in protein-
protein complex, and remains broadened in the ternary complex. For
this signal strong ST effect is observed when in complex with RNA. This
residue is involved in initial viral RNA recognition, but then RNA is
displaced from this site by ALYREF binding.
doi:10.1371/journal.ppat.1003907.g005
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demonstrated by the fluorescence measurements and supported by
the remodeling assay, while the local competitiveness of RNA and
ALYREF binding to R-b helix is directly demonstrated by the
NMR data, and additionally supported by the fluorescent
measurements showing ternary complex dissociating when over-
titrated with RNA. The RNA binding within the stoichiometric
Figure 6. Fluorescent studies and simulations of the ternary
complex formation between ORF57, O, fragment of viral RNA,
R, and ALYREF, A. (A) Simultaneous non-linear fit of normalized
fluorescence-derived parameters DlNbcm (blue shift of emission signal)
and DIN (fluorescence quenching) to the non-redundant three-equation
model using DynaFit software, to obtain Kd for the ternary complex. The
experimental values of thus determined Kd
OA+R, as well as Kd’s for other
complexes measured earlier, are summarized on two illustrative
thermodynamic cycles for the ternary complex assembly presented
on panels (B) and (C). Simulations (using COPASI software [67]) for these
two possible cycles illustrate an increase in the concentration of ternary
ORF57-RNA-ALYREF complex when ORF57 is added to 10 mM equimolar
mixture of ALYREF and RNA, assuming the simplest four-state
equilibrium model (B), or six-state model which additionally takes into
account weak nonspecific ALYREF-RNA binding (C). The arrow marks a
point where all the components of ternary complex are present in
equimolar amounts. The presence of equimolar ORF57 significantly
increases the concentration of RNA in complex with ALYREF (i.e., [OAR]
vs [AR][O] = 0). The baseline concentrations [AR][O] = 0 are indicated on the
panel (C) on the left, assuming two different conservative estimates for
values of Kd for nonspecific ALYREF-RNA binding.
doi:10.1371/journal.ppat.1003907.g006
Figure 7. Probing ORF57-RNA binding by mutations and UV
cross-linking, and ALYREF-ORF57-RNA remodeling assay. (A)
Purified hexa-histidine tagged GB1 (negative control) or ORF578–120 WT
and point mutants (as labeled) were incubated with end-labeled
14merS RNA oligonucleotide before the mixture was subjected to
UV cross-link (+) or not (2). Similarly in the remodeling assay, WT
ORF578–120 was incubated with end-labeled 7merS (B) or 14merS (C),
before the mixture was added to purified GST-ALYREF immobilized
onto glutathione coated beads. Purified complexes were eluted in
native conditions and UV cross-linked (+) or not (2). All samples were
finally analyzed on 15% SDS-PAGE stained with Coomassie blue and by
PhosphoImaging.
doi:10.1371/journal.ppat.1003907.g007
Viral mRNA Transfer from HVS ORF57 to ALYREF
PLOS Pathogens | www.plospathogens.org 9 February 2014 | Volume 10 | Issue 2 | e1003907
ternary complex is mapped using direct NMR measurement of
spatial proximity of individual amino acid residues of both ORF57
and ALYREF to RNA (Fig. 8). When the ternary RNA-ORF57-
ALYREF complex is formed, the N-terminal regions of both
ORF57 and ALYREF in contact with RNA retain significant
flexibility (as evidenced by NMR signal shapes and lack of RNA-
protein NOEs). The main NXF1-binding region of ALYREF
aa15–36 [5,10] partially overlaps with region involved in viral
mRNA binding, and remains sufficiently exposed. This allows us
to speculate that at the next stage of the pathway the NXF1 would
bind to this region, partially displacing the viral mRNA, which
however will be held in the vicinity by the rest of the binding site,
formed by synergetic interactions of ALYREF and ORF57.
ALYREF binding would then help switch NXF1 into the high-
affinity RNA binding mode, forcing it to accept viral mRNA for
export via the nucleopore, using the host pathway. We suggest that
the presence of partially-overlapping binding sites, and a
combination of competitive interactions at the level of specific
sites, and cooperative binding at the macroscopic level, may
provide a general molecular mechanism for targeted successive
RNA transfer between protein molecules along the export
pathway.
Discussion
The functional role of the viral protein ORF57, to introduce
specific viral RNA to the cellular protein ALYREF, thereby
facilitating the export from the nucleus of unspliced viral mRNA
via the NXF1-dependent cellular pathway, is fulfilled via several
critical properties. First, ORF57 must recognize a specific viral
mRNA, which contains characteristic sequence motifs, and ignore
cellular mRNA. Second, it should interact with cellular ALYREF,
and induce binding of a specific viral mRNA to ALYREF,
allowing ALYREF then to pass it over to NXF1 at the next stage
of the pathway. Therefore, the ability to recognize and reversibly
bind RNA is crucial for correct and efficient functioning of viral
ORF57 as a ‘‘molecular highjacker’’ of the host cell pathway.
Here, we have reconstituted in vitro and studied in detail the
function of the core responsible for the recruitment of viral RNA
to ALYREF, using the essential protein fragments of ORF57(aa8–
120) and ALYREF(aa1–155) which interact with each other and
with viral RNA. A range of experimental approaches was used to
reveal the molecular mechanism of viral RNA recognition and
following transfer from ORF57 to ALYREF with atomic-to-
residue-level resolution.
Functional importance of RNA recognition region of
ORF57
The position of viral mRNA binding sites on ORF57 was
previously broadly localized to aa8–120 [20,21]. This region is
largely unstructured, and contains multiple arginines between
residues 62 and 120 which may potentially mediate RNA binding,
although this was not confirmed previously. Here, we used NMR
to characterize the binding sites more precisely. To directly
identify the residues in proximity to RNA we employed
RNARprotein cross-saturation transfer experiments [37,39]
which revealed two main ORF578–120 regions in direct contact
with RNA, aa107–120 and aa81–92, with residues from aa94–105
and aa64–79 also contributing. Although the general ‘‘polyelec-
trostatic effect’’ [45] is expected to attract mostly negatively-
charged RNA to positively-charged regions and thus explain the
weak RNA-binding affinity of ALYREF, the amino acid sequence
determinants of a sequence-specific RNA recognition by viral
ORF57 are still to be explored. It should be noted that the specific
RNA recognition by flexible charged polypeptide regions is not
unprecedented, and similar examples have been described in the
literature [46–49]. The mapping of RNA binding regions using
NMR is also fully supported by the biochemical data. Mutations of
selected residues (Y81+R82, R88+F89 and W108+R111+V112) to
alanine within these regions reduced the efficiency of UV RNA-
ORF578–120 cross-linking, confirming their involvement in medi-
ating RNA binding (Fig. 7A). Moreover, earlier we probed the
physiological effect of a number of mutations in this region via an
ex vivo assay for cytoplasmic accumulation of an HVS ORF47
reporter mRNA, which reflects the ability of full-length ORF57
(bearing site-specific mutations) to form an export competent
ribonucleoprotein particle [30]. Mutations within R-b helix of
W108A, R111A, V112A, R119A and R120A and their combi-
nations all substantially reduced the efficiency of the mRNA
cytoplasmic accumulation, which was previously interpreted as a
confirmation of the functional significance of ORF57 – ALYREF
interaction for ORF57-mediated nuclear export of viral mRNA
[30]. In view of the new experimental data, the same R-b-helix
region is also directly involved in viral mRNA binding, meaning
that the physiological effect of these mutations cannot be solely
attributed to blocking ORF57 – ALYREF interactions, but these
mutations will likely affect the whole process of how viral mRNA is
Figure 8. Model of the passage of RNA between ORF57 and
ALYREF. Local protein interactions with RNA are detected by
moderate (orange) and large (red) saturation transfer effects (repre-
sented by ‘lightning bolts’) observed by ST-HSQC or ST-IDIS-TROSY and
mapped onto respective regions. Broadened residues are colored light-
yellow. Linked black circles represent a position for transiently bound
RNA. ALYREF (green) binds RNA 14merS weakly via its RRM and N-
terminal regions (A), whereas ORF57 (blue) binds 14merS tightly mainly
via the R-b helix and also the aa81–92 region (B). Interaction of ORF57-
RNA complex with ALYREF partially displaces the RNA from the R-b
helix, while RNA maintains contact with ORF57 aa81–92 and also forms
new contacts with ALYREF’s aa22–48 and helix-2 of the RRM domain (C).
The RNA contacts with ALYREF within the ALYREF-ORF57-RNA ternary
complex are more abundant than for just ALYREF-RNA, and thus ORF57
enhances the interaction of viral RNA with ALYREF.
doi:10.1371/journal.ppat.1003907.g008
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recognized and introduced to ALYREF. Additionally, mutations
R79A+V80A and R94A+I95A in the flanking region also reduced
noticeably the cytoplasmic accumulation [30], which now can be
explained by the involvement of this region in mRNA binding.
These previously obtained physiological assay data obtained with
full-length proteins thus corroborate the functional importance of
the molecular regions characterized here in detail using shorter
molecular fragments. Future in vivo studies using all these ORF57
mutations introduced in live HVS, and monitoring their effect on
the process of cell infection and time-dependent localization of
interacting components, are expected to clarify further the order of
binding events mediated by the R-b-helix and flanking RNA-
binding regions in the context of live cell. The mutations most
detrimental to HVS are expected to involve residues situated on
the R-b helix which participate in both ALYREF and viral RNA
binding. The results presented here provide a map for further
extensive mutational analysis, and a framework for its functional
interpretation in vivo.
Structure of ALYREF- ORF57 interaction interface
The ALYREF-ORF57 structure determined here shares some
similarities with the ALYREF-ICP27 structure [30] (Fig. 3) as both
viral peptides make similar contacts with a patch on ALYREF’s
surface. There are however clear differences between the
ALYREF-ICP27 and ALYREF-ORF57 complexes, not discov-
ered in the earlier signal perturbation mapping analysis [30]. The
ORF57 fragment is helical and mainly contacts the looped side of
ALYREF, whereas ICP27 has an extended conformation and
stretches along the groove formed by a-helices of ALYREF RRM
(Fig. 3). As a result, the ALYREF-ORF57 complex is superficially
more similar to U2AF homology motif (UHM) recognition [50] of
Trp containing peptides (Fig. 3D), although ALYREF lacks the
signature Arg-X-Phe UHM interacting motif [51]. It is therefore
apparent that variations in sequences and local structures of viral
adaptor proteins can achieve similar binding with the promiscuous
RRM domain of ALYREF [52]. This may explain the lack of an
obvious conserved ‘‘ALYREF-binding motif’’ in other herpes viral
adaptor proteins, such as KSHV ORF57 or EBV EB2 [17,18,53].
We previously suggested a recognition triad for ALYREF,
namely W105, R107, L108 in ICP27 and W108, R111, V112 in
ORF57 [30]. The functional role of this triad in ICP27-ALYREF
binding in vivo, and for efficiency of viral mRNA export and HSV-
1 production was also studied in detail recently [54]. In light of the
new structural data presented here, the importance of R113ORF57
should also be emphasized as it plays a similar role to that of
R107ICP27 [30]. The quantitative differences in mutational effects
of the triad residues W105AICP27/W108AORF57 and L108AICP27/
V112AORF57 on binding with ALYREF [30] can now be
explained by the subtle differences in their structural context.
The structure of ORF57-ALYREF complex also provides an
explanation for the weak affinity of a short ORF57 aa105–115
peptide and ORF578–120 double mutant R119A+R120A [30], as
both constructs are likely to disrupt helix formation and increase
the entropic cost of binding.
Cooperative and flexible nature of the ORF57-RNA-
ALYREF complex assembly
Using the combination of traditional atomic-resolution structure
determination and novel saturation-transfer experiments we were
able to follow the process of RNA transfer from ORF57 to
ALYREF in a site-specific manner, and suggest a model of how
the ternary complex is assembled (Fig. 8). It is interesting that the
signal intensity of the N-terminal region aa22–48 of ALYREF does
not reduce significantly upon RNA binding in the presence of
ORF57, suggesting that this interaction is relatively transient.
Overall, we conclude that ORF57 simply bridges the interaction
between viral RNA and cellular ALYREF, cooperatively enhanc-
ing the formation of the ternary complex, without allosterically
remodeling ALYREF. The overall cooperativity of the ternary
complex formation is demonstrated by the quantitative Kd
measurements for the different complexes within the thermody-
namic cycle (Fig. 6B). The cooperativity of interactions explains
the partial RNase sensitivity of the ALYREF-ORF57 complex
reported previously [21]. The same cooperativity may also explain
why the presence of ORF57 in the nucleus of an infected cell does
not cause indiscriminate export of non-viral mRNAs which lack
the specific viral sequence motif. The estimates using NMR and
fluorescence experiments showed that the apparent Kd of binding
of specific RNA oligonucleotide to equimolar ALYREF1–155 –
ORF578–120 complex (1.55 mM) is lower than to ALYREF1–155
(.50 mM) or ORF578–120 (7.57 mM) individually. The inferred Kd
of ALYREF binding to ORF57-RNA complex (Fig. 6B) is
0.52 mM, two orders of magnitude tighter than for ALYREF-
RNA binding. These estimates support that the ternary complex
overall is stabilized cooperatively, despite the presence of local
competition between RNA and ALYREF for ORF57 R-b helix
region aa106–120.
It is notable that the values of NMR signal shifts within the
flexible regions were not a good indicator of the formation of
transient complexes with RNA. It is likely to be due to a
substantial fluidity of the complex leading to extensive chemical
shift averaging over the conformational ensemble; however the
saturation transfer from RNA protons to protein amides served as
a more reliable indicator of local binding. The ternary complex
formed here may present a good example of fuzzy complexes, the
existence of which was postulated recently [55,56]; more
specifically, it would fit the ‘‘flanking’’ model, where the short
R-b helix acts as a clamp forming more rigid part of the complex
interface, whereas transient interactions within flexible flanking
regions contribute to the overall stability of the complex. Such a
mode of recognition, using fairly short linear motifs located within
flexible regions of viral proteins, is expected to provide evolution-
ary advantages for quick adaptability of viruses [56–59], and may
fit well with a necessity to bind and remodel NXF1, and dismantle
the RNA-ALYREF-ORF57 complex at the next step of the viral
mRNA export pathway.
Implications for viral mRNA export
The protein constructs used here comprise the main binding
elements for the assembly of the specific ORF57-RNA-ALYREF
ternary complex, which is responsible for introducing the
herpesviral mRNA to the cellular export factor ALYREF.
However, both native ALYREF and ORF57 contain additional
regions which may contribute to the binding of longer viral
mRNA molecules, adding to the overall cooperativity of this
assembly, and strengthening it further. The viral mRNA
transcripts, which are much longer than oligos used in the current
study, would provide additional contact points for RNA-binding
regions within the C-terminal regions of both full-length ALYREF
[7,8] and ORF57 [23]. Therefore, the quantitative measurements
of binding reported here for the essential core of the ternary
complex provide only a lower affinity estimate for the full-length
complex. We speculate that once the ternary ORF57-mRNA-
ALYREF complex encounters NXF1-p15, viral mRNA will be
displaced from the N-terminus of ALYREF where NXF1 binds in
its place [5,10]. Viral mRNA at that moment will still be retained
by ALYREF’s RRM domain together with ORF57, presenting it
to NXF1. Binding of ALYREF switches NXF1 into a high-affinity
Viral mRNA Transfer from HVS ORF57 to ALYREF
PLOS Pathogens | www.plospathogens.org 11 February 2014 | Volume 10 | Issue 2 | e1003907
RNA-binding mode [5,6], forcing it to accept the foreign viral
mRNA and commit it to export to the cytoplasm. As indicated
earlier, the adaptor proteins homologous to HVS ORF57 (ICP27
in HSV-1, ORF57 in KSHV) are expressed by all herpesviridiae.
The location of RNA binding sites within these proteins is poorly
conserved, and the exact location of binding sites with cellular
adaptors such as ALYREF [17] and UIF [19] often is unknown or
not evident due to the lack of recognizable sequence motifs
responsible for such binding. Even when superficial similarity
exists, as in the case of ALYREF recognition triad residues
suggested earlier for HSV-1 ICP27 and HVS ORF57 [30], here
we showed that in fact the structural details of the molecular
recognition are significantly different, despite binding occurring in
the same cleft on the surface of the RRM of ALYREF. This
finding means that it is probably too early for modeling and
predictions to be used to discover the binding interfaces between
RNA and viral and cellular proteins, and detailed experimental
structural studies need to be continued for this molecular
pathogen-host system, with different herpesviruses using diverse
strategies for molecular recognition to achieve a similar functional
outcome, such as viral mRNA export. Continuation of similar
studies for signature viral adaptors from more medically relevant
herpesviruses, such as HSV-1 or KSHV involved in cancer, may
possibly identify new drug targets for novel treatments.
This work for the first time suggests a detailed mechanism for
the assembly of the key ternary RNA-ORF57-ALYREF complex
leading to herpesvirus highjacking the host nuclear export
pathway. We show the importance of partially-overlapping
multifunctional binding sites and combination of competitive
and cooperative binding events as a likely mechanism for the
orderly assembly and disassembly of mRNA nuclear export
complexes and molecular transfer, adding to the emerging
knowledge in this area [35,36,60,61].
Materials and Methods
Protein expression and purification
All proteins were expressed in E. coli BL21-RP cells (Novagen). For
NMR studies, murine ALYREF (also called REF2-I) isoform
constructs aa1–155 (ALYREF1–155), aa54–155 (ALYREF54–155),
as well as ORF5756–140 and ORF578–120, were produced as
described previously [30]. ALYREF protein constructs are
identical to protein REF used in [30]; only name was changed
due recent gene naming conventions [31]. ORF57103–120 peptide
was produced as a GST-fusion construct as described for
ICP27103–138 [30]. Post gel filtration, all samples were buffer
exchanged using an Amicon ultrafiltration cell to the NMR buffer
(20 mM phosphate pH 6.2, 50 mM NaCl, 50 mM each of L-Arg,
L-Glu and b-mercaptoethanol, 10 mM EDTA); L-Arg and L-Glu
were added to reduce protein aggregation and improve sample
stability [62]. Unlabelled synthetic peptide ORF57103–120 was
obtained from Peptide Protein Research Ltd (UK). For UV cross-
linking, hexa-histidine ORF578–120, hexa-histidine GB1 and GST-
ALYREF fusions were purified by affinity chromatography and
dialyzed against RB100 buffer (25 mM HEPES pH 7.5, 100 mM
KOAc, 10 mM MgCl2, 1 mM DTT, 0.05% Triton, 10%
Glycerol).
NMR experiments
All experiments were carried out at 30uC on Bruker DRX600,
DRX700 and Varian Inova 800 MHz spectrometers equipped
with cryoprobes, and a Bruker DRX800 with a room temperature
probe. Standard triple-resonance experiments were used to assign
spectra: ORF57103–120 in free form and with a 3-fold excess of
unlabelled ALYREF54–155 added, ORF5756–140 in the free form,
and ALYREF54–155 with a 3-fold excess of ORF57103–120 synthetic
peptide added. ALYREF54–155, ALYREF1–155 and ORF578–120
were assigned previously [10,30]. Spectra were processed using
NMRpipe [63] and Topspin 2.1 (Bruker) and analyzed using
Sparky (University of California). Distance restraints obtained
from 3D 15N- and 13C- edited NOESY-HSQC experiments (tm
130 ms) and dihedral restraints from TALOS+ [42] were used in
structure calculations by CYANA [64]. Additionally, intermolec-
ular contacts were unambiguously identified using 13C-edited,
12C-filtered NOESY-HSQC (tm 150 ms) spectra acquired on a
Varian Inova 800 MHz spectrometer. In this experiment only
NOE crosspeaks between 1H-13C moieties of 13C,15N-labelled
ALYREF and 1H(12C) of unlabelled ORF57 were observed
[65,66]. A final ensemble contained 20 structures with lowest
target function values. Images were generated using Pymol (DeLano
Scientific). Chemical shift assignments were submitted to the
BioMagResBank for free ORF57103–120 (bmr17664), free
ORF5756–140 (bmr17663) and the ALYREF-ORF57 complex
(bmr17693). Structure coordinates and experimental constraints
for ALYREF-ORF57 complex were deposited into the Protein
Data Bank (2yka). Ramachandran plot statistics for residues in
most favored regions, additional allowed regions, generously
allowed regions, disallowed regions calculated for structured
ALYREF74–152+ORF57106–120 are: 79.8%, 20.2%, 0%, 0%.
IDIS-TROSY spectra [38] were acquired using 1:1 mixtures of
0.4 mM 13C,15N-labelled ORF578–120 and 15N-labelled
ALYREF1–155 or ALYREF54–155, followed by additions of RNA.
RNA oligonucleotides were obtained from Sigma. Two oligos
contained the ORF57-specific motif [32] GAAGAGG (7merS)
and CAGUCGCGAAGAGG (14merS), and two were non-
specific CAGUCGC (7merN) and CAGUCGCAUAGUGCA
(15merN; this oligo is identical to that used previously [10]).
Irradiation of resolved RNA signals [39] in cross saturation
transfer (ST) [37] versions of standard Bruker-library HSQC,
TROSY and IDIS-TROSY [38] was achieved by using a selective
Gaussian pulse train (lasting 0.7 s in total) using a series of 8.5 ms
180 degree pulses (B1 = 60 Hz). The saturation pulse train was
tagged at the end of relaxation delay of 2.3 s, immediately prior to
the first hard proton pulse. RNA peaks were selectively irradiated
by centering the pulse train at 5.85, 5.75 or 12.00 ppm
frequencies, with off-resonance irradiation at 21 ppm. Ratios of
amide signal intensities in equivalent spectra, obtained with
saturation at two different frequencies freq1 and freq2 (as indicated)
were obtained. Residues were highlighted as close to RNA in
space if the ratio of signal intensities Ifreq1/Ifreq2 differed significantly
from unity (by more than three standard deviations (SD),
calculated from the Ifreq1/Ifreq2 variability observed within non-
interacting regions).
UV cross-linking of RNA with ALYREF and ORF57
RNA oligonucleotides were end-labelled with [c32P]-ATP using
Polynucleotide Kinase (Fermentas). UV cross-linking with proteins
was performed as previously described [10]. For the in vitro
reconstitution assay, 10 or 100 mg ORF578–120 was incubated with
5 mg radiolabelled and cold RNA (7merS or 14merS) at room
temperature for 10 minutes. The mixture was added to 20 mg of
GST-tagged full length ALYREF (aa1–218) immobilized onto
Glutathione-coated beads (GE Healthcare) in RB100 buffer. Beads
were washed and complexes were eluted in native conditions
(50 mM TRIS pH 7.5, 100 mM NaCl, 40 mM reduced glutathi-
one) before being subjected to UV-irradiation or not. Proteins
were resolved on 15% SDS-PAGE stained with Coomassie blue
and analyzed by PhosphoImaging.
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Fluorescence experiments
Purified proteins were transferred into buffer F (20 mM
phosphate pH 6.2, 50 mM NaCl, 50 mM L-Arg+L-Glu, 5 mM
EDTA, 1 mM TCEP) by 3 overnight dialysis steps and then
concentrations determined by UV absorption (280 nm). Measure-
ments were carried out on a Varian Cary Eclipse fluorimeter, with
excitation at 280 nm and emission monitored over 290–600 nm at
a scan rate of 120 nm/min. Titrations were carried out with at
least 1 min of equilibration time after each addition. ORF578–120-
RNA (OR) titrations were performed using 13 mM ORF57,
titrations of 1:1 ORF57-ALYREF (OA) with RNA used an initial
protein concentrations of 2.5 and 10 mM. Blue shift in emission
maximum was caused by protein-protein (OA and OAR) complex
formation and was quantified as a change in barycentric mean
values lexpbcm~
P
lIlP
Il
(‘‘centre of mass’’ of the peak), where l is
emission wavelength (320–390 nm) and Il is fluorescence intensity
at this wavelength. Binding of RNA to ORF57 (in OR and OAR
complexes) was quantified by measuring a decrease in integral
fluorescent intensity Iexp~
P
Il. Apparent macroscopic dissocia-
tion constants Kd for binary complexes were obtained by non-
linear regression fit of l
exp
bcm and I
exp dependences on the total
concentration of added component, using either a standard
quadratic equation, or DynaFit software (BioKin Ltd) [43] which
produced the same results. Value of apparent macroscopic Kd for
ternary complex formation was obtained by titrating RNA
(14merS) to 10 mM 1:1 ALYREF-ORF57 mixture, followed by
simultaneous fitting of the associated changes in lexpbcm and I
exp to
the non-redundant three-equation equilibrium model (Fig. 6A)
using DynaFit [43]. Changes in normalized fluorescence param-
eters, caused by the increase in [OA] or/and [R], were related
with concentrations as DlNbcm~
l
exp
bcm
{l0bcm
n
~a½OAzb½OAR, and
DIN~ I
exp{I0
m
~c½ORzd½OAR, with the values of the response
coefficients a, b, c and d and normalization factors n and m
obtained during the nonlinear fit (so that a= 1<b and c= 1<d, and
all concentration expressed in mM units). Further simulations of
equilibrium reactions within different binding models were
conducted using COPASI software [67].
Supporting Information
Figure S1 NMR mapping of RNA interactions with
ORF57, ALYREF and the ALYREF-ORF57 complex. (A)
Chemical shift changes in ORF578–120 induced by addition of
RNA oligos: blue diamonds - 7merS (ORF57:RNA ratio of 1:1),
blue crosses - 7merS (1:0.5), green open triangles - 7merN (1:2)
and green closed triangles - 15merS (1:2). Blue diamonds
positioned at the top mark residues with signals broadened
beyond detection. (B) 15N{1H}-NOEs do not change significantly
in response to addition of non-specific RNA: blue diamonds are
for free ORF578–120, blue crosses - ORF578–120:7merN (1:2), red
squares - free ORF5756–140, and red dashes - ORF5756–140:7merN
(1:2). (C) Overlay of 1H-15N HSQC spectra of ORF57103–120 in
the absence of RNA (red) and with three-fold excess of RNA
7merS (green) added. Sidechain amide signals are labeled with
asterisks. (D) Scheme illustrating the original principle of the ST-
HSQC cross-saturation experiment for determining the binding
interfaces between RNA and 15N-labeled protein [37,39]. RNA
signals are selectively saturated by radiofrequency (RF) pulses,
which causes change in NMR signal intensity of adjacent protein
amides (detected in 1H-15N correlation spectra). (E) Saturation
transfer from 7merS (green) and 7merN (red) to ORF57 amides,
using ORF57:RNA ratios of 1:0.5 and 1:2 respectively, measured
by ST-HSQC experiment. (F) Saturation transfer from 14merS
RNA to the N-terminal region of ALYREF1–155 (ALYREF:RNA
ratio 1:0.5) measured by ST-HSQC. ST-IDIS-TROSY (G and H)
was used to simultaneously detect RNA contacts with ORF578–120
(i) and ALYREF1–155 (ii) when these two differentially-labeled
proteins and unlabelled RNA formed a single equimolar complex.
ST from 14merS to ORF578–120 and ALYREF1–155 in complex
are shown for two saturation schemes, with calculated ratios of
signal intensities I5.75/I5.85 (F) and I12.0/I21.0 (H). Dashed
horizontal lines show the levels of three standard deviations from
the mean baseline values.
(EPS)
Figure S2 NMR derived evidence for presence of an a-
helix in ORF57. ORF57 region aa108–118 is a-helical. (A) Long
axis view of helix showing its amphipathic nature. (B) Model
constructed using experimental dihedral angles and NOE
restrains. (C) Position of the a-helix (named here R-b helix)
determined from backbone dihedral angle values using TALOS+
(Shen, Y., et al. 2009, J Biomol NMR 44, 213–223) in three ORF57
constructs with different domain boundaries.
(TIF)
Figure S3 Overview of spectral data for ALYREF54–155-
ORF57103–120 complex. 1H-15N-HSQC spectra of (A)
ALYREF54–155 free (red) and bound to HVS ORF57103–120 (blue)
or bound to HSV-1 ICP27103–138 (pale green), and (B) ORF57 free
(red) and bound to ALYREF54–155 (blue). Both viral peptides cause
perturbations within same ALYREF residues showing that they
bind to the same site, but the direction of signal movements mostly
differ, suggesting some differences between the interactions.
Sidechain amide signals are labeled * and signals from N- or C-
terminal tag sequences are labeled x. NMR derived parameters
obtained for ALYREF-ORF57 and ALYREF-ICP27 interactions
are summarized for (C) ORF57103–120 and (D) ALYREF54–155.
Residues with large and moderate reductions of mobility upon
binding, as evidenced by the increase in 15N[1H] NOE, are
highlighted by solid and broken bars mark, respectively. Similarly,
large and moderate changes in chemical shifts (dCS) of amide
signals are shown as solid and broken bars, respectively. Red or
orange bars mark residues forming direct inter-molecular NOE
contacts in ALYREF-ORF57 or ICP27 complexes, respectively.
The position of secondary structure elements (a-sheets, b-helices
and loops) is shown. Data for ORF578–120 and ICP27103–138
marked with asterisks was previously released (Tunnicliffe, R. B.,
et al. 2011, PLoS Pathog 7, e1001244.) and is included here for
comparison.
(EPS)
Figure S4 NOE-derived distance constraints used in the
structure calculation of the ALYREF54–155 : ORF57103–120
complex. The position of short and medium range NOE
connectivities are shown in (A) for ALYREF and (B) for ORF57.
The sequences colored blue highlight tags introduced in cloning.
(C) The distribution of all NOEs on a per residue basis. White,
light grey, dark grey and black shading of bars indicates the
number of meaningful intra-residue, sequential (i+1), medium
(2#i#4) and long (5#i) range constraints. Two samples were used
for structure determination of the ORF57103–120: ALYREF54–155
complex, these contained one protein 13C,15N uniformly labeled at
1 mM plus the binding partner in unlabelled form at 3 mM. Over-
titration of the labeled component was necessary to observe the
signals otherwise broadened in the equimolar complex. (D)
Intermolecular NOE restraints used in structure calculations are
shown schematically between the individual residues of ALYREF
and ORF57. Positions of two a-helices of ALYREF are marked.
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Each line corresponds to a non-redundant NOE restraint. Dark
green continuous lines represent NOEs obtained unambiguously
from 13C edited, 12C-filtered NOESY-HSQC spectra. Additional
NOEs represented by light green dashed were obtained from more
sensitive standard 3D 13C-resolved NOESY-HSQC spectra. (E)
Example sections of 3D 13C edited, 12C-filtered NOESY-HSQC
spectra showing intermolecular NOEs. Positive signals are colored
green and negative red. ORF57 1H signal assignments are shown
in blue and ALYREF 1H assignments shown as vertical orange
dashed lines. The experiment selects NOE cross peaks between
1H(12C) of unlabelled ORF57103–120 and 1H-13C moieties of
[13C,15N]- ALYREF54–155, therefore providing exclusively inter-
molecular restraints.
(EPS)
Figure S5 1H-15N correlation spectra of ALYREF1–155
(i) and ORF578–120 (ii) in different binding states
illustrate that the presence of ALYREF partially
shields ORF57 from binding specific RNA 14merS.
Where indicated with arrows, the spectra of differentially-
labeled proteins were acquired simultaneously in the same
sample using IDIS-TROSY experiment. (A) TROSY spectra of
proteins in free form (red) are overlaid with IDIS-TROSY of a
1:1 complex (blue). The signals from residues at the protein-
protein interface are exchange broadened, but signal shifts from
other residues nearby are characteristic to complex formation.
(B) An equimolar amount of HVS-specific RNA oligo 14merS
was added to this ALYREF:ORF57 complex (grey), which
induced signal changes mostly in ALYREF and to small extent
in ORF57. (C) For comparison, addition of the same RNA oligo
to ALYREF in the absence of ORF57 causes identifiable signal
shifts on ALYREF, as revealed by comparison of HSQC
spectra. Addition of the same RNA oligo to ORF57 in the
absence of ALYREF causes very extensive peak broadening in
the whole C-terminal half of ORF578–120. The examples of
IDIS-TROSY spectra shown in (A) and (B) illustrate the ability
to monitor in both proteins the individual signal changes caused
by inter-protein complex formation, and further changes on
both proteins caused by the addition of RNA.
(EPS)
Figure S6 The local ORF57-ALYREF interaction is
stronger than the ORF57-RNA. Same type of experiments
are presented as shown on Figure S5, but using ALYREF54–155 (i)
(which lacks the N-terminal RNA-binding region), ORF578–120 (ii)
and a shorter specific RNA 7merS. (A) TROSY spectra of protein
in free form (red) are overlaid with IDIS-TROSY of a 1:1 complex
(blue); signals from residues at the protein-protein interface are
exchange broadened, while movements of signals from residues
close to the interface are characteristic to protein-protein complex
formation. (B) An equimolar amount of HVS-specific RNA oligo
7merS was added to this complex (grey), which induced very
limited signal changes in ALYREF and even less in ORF57. (C)
For comparison, addition of the same RNA oligo to ORF57 in the
absence of ALYREF causes very extensive peak broadening in the
whole C-terminal half of ORF578–120.
(EPS)
Figure S7 Estimates of binding affinities using fluores-
cence. ORF578–120 (13 mM) was titrated with RNA oligos
14merS (A) and 7merN (B), and change in integral fluorescence
emission intensity DI was monitored. The values of Kd shown were
obtained using DynaFit software (BioKin Ltd) [43]. The
satisfactory fit to the experimental data could be achieved only
assuming 1:1 binding stoichiometry. (C) Formation of protein-
protein complex (by increasing concentrations of ORF578–120:
ALYREF1–155, [O,A]) causes blue shift of fluorescence emission
peak, as measured by a change in lbcm. The upper panel shows
fluorescence spectra normalized by protein concentration, with
concentration for each sample in mM units marked on the right.
The bottom panel shows non-linear best-fit of DlNbcm to the
standard quadratic equation; the estimated apparent Kd for
ORF57-ALYREF binding is 2.56 mM. (D) Addition of specific
RNA oligo to equimolar mixture of ORF578–120: ALYREF1–155
(OA) first further enhances blue shift of fluorescence which is
consistent with the ternary complex formation, however over-
titrating this complex with excess RNA (above 5-fold) causes
fluorescence maximum shift in the opposite direction, consistent
with dissociation of protein-protein complex formed earlier. The
inset illustrates typical behavior of the fluorescence signal in
response to addition of RNA to 2.5 mM protein-protein complex.
Experimentally measured values for 10 and 2.5 mM complexes are
represented with diamonds and triangles, respectively. The solid
lines represent typical theoretical binding curves calculated using
equilibrium models shown on Fig. 6B,C and COPASI software
[67]. These models adequately fit the experimental data when
concentration of RNA is close to stoichiometric, but fail to
describe correctly the competitive binding of RNA to ORF57 and
ALYREF separately, when RNA is in large excess, leading to
ternary complex dissociation. More sophisticated binding models,
with more parameters included, and more measurable observed
experimentally, would be needed in the future to describe the
binding behavior of this complex system in the wider range of
component concentrations.
(TIF)
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